ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed
Fenghua Liu
Matched on ORCID iD 0000-0002-3860-9466; OpenAlex author ID A5100325256. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2012: 2 papers · 2013: 1 paper
Papers 3
- Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation First author DOI 10.1186/1756-9966-32-42↗
- Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. First author DOI 10.1186/1756-9966-31-73↗
- Regional intra-arterial vs. systemic chemotherapy for advanced pancreatic cancer: a systematic review and meta-analysis of randomized controlled trials. Co-author DOI 10.1371/journal.pone.0040847↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chunning Zheng · 2 shared papers, 2012–2013 · strength 0.09
- Paper Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation DOI 10.1186/1756-9966-32-42↗
- Paper Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. DOI 10.1186/1756-9966-31-73↗
- Yingsheng Jiang · 2 shared papers, 2012–2013 · strength 0.09
- Paper Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation DOI 10.1186/1756-9966-32-42↗
- Paper Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. DOI 10.1186/1756-9966-31-73↗
- Yong Mei Tang · 2 shared papers, 2012–2013 · strength 0.09
- Paper Correction: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation DOI 10.1186/1756-9966-32-42↗
- Paper Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. DOI 10.1186/1756-9966-31-73↗
- Junwei Sun · 1 shared paper, 2012 · strength 0.03
- Jihui Hao · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.